Thermo Fisher Scientific expanded capacity at the North American site for sterile drug products in Greenville, NC and will now perform non-GMP work to support clinical phase programs. The new development laboratory features two LyoStar3 freeze dryers with SMART technology that are capable of decreasing the number of runs required for lyophilization cycle development.
The purpose built, state-of-the art facility will help address the growing demand for development supply chain services and will focus on high quality secondary packaging solutions for customers and their patients. The new site will provide clinical trial support services including GMP storage, local labeling, secondary packaging, comparator sourcing, and handling and distribution of ambient and cold chain clinical trial supplies through to returns management.
Thermo Fisher dedicated its newly installed training center, designed with industry-leading resources and technologies, on Monday, August 19th, 2019. The facility is equipped with virtual reality and augmented reality capabilities, which will mimic a real-world operating environment and equipment, and reduce the amount of training time by 50%.
Thermo Fisher recently expanded their steriles capabilities to support clients requiring auto-injector devices for patient self-administration. Located in dedicated and flexible GMP-compliant cabins, Thermo Fisher can accommodate both small and multi-million unit runs. This further increases the company’s breadth of sterile services, which also includes cartridge and vial fill-finish, prefilled syringe assembly, primary and secondary packaging, and label services.
